Bethany Hills Grois: Harnessing AI to Revolutionize Cancer Screening

Bethany Hills Grois shared a post on LinkedIn:

“Harnessing AI to Revolutionize Cancer Screening: You don’t want to miss this webinar next MONDAY (That’s me with my “listening intently” face , I’ll be dialed in listening and learning.)

Monday, September 23, 2024
8:00 am PT, 11:00 am ET, 17:00 CET

In this FREE webinar, moderated by Sanjay Juneja, M.D. (Hematologist & Medical Oncologist at Mary Bird Perkins Cancer Center) expert panelists (Douglas Flora, MD, LSSBB, FACCC, Sarah M. Dunlap, Ph.D., Ph.D., Robert Smith, Lecia Sequist, MD) will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges.

Register now to join us.”

Source: Bethany Hills Grois/LinkedIn

Bethany Hills focuses her practice on life science and health care. She advises life sciences and health tech industry clients on the full range of regulatory compliance issues, bringing together FDA regulatory, healthcare regulatory and life science compliance expertise. Bethany helps her clients manage complex, multi-faceted regulatory compliance issues in product development, product launch, ongoing market compliance and defends private and government enforcement actions. 

Bethany has deep expertise in digital health issues and experience in artificial intelligence and software solutions in the life science and health care industry. She manages complex GXP issues for regulated companies and manages agency engagement and product correction and recall strategies when issues are identified. Bethany has expertise in the intersection of FDA and healthcare regulatory, including pharmacy regulation, DEA, CLIA, state licensure, clinical trial compliance and innovation, and corporate practice of medicine issues.